Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kim Blickenstaff Insider Profile
11 Followers
Kim Blickenstaff, Director at Tandem Diabetes Care, holds 172.19K shares in Nuvation Bio (Ticker: NUVB), holds 223.04K shares in Tandem Diabetes Care (Ticker: TNDM), holds 7.38K shares in Medivation (Ticker: MDVN). Most recently, Kim Blickenstaff Bought ― shares of Nuvation Bio on Jun 13, 2024 for an estimated value of 499.35K.
Profitable Transactions
9 out of 23 Profitable Transactions
Average Return
+62.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kim Blickenstaff holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 17, 2017 - Oct 17, 2018
Return:+800.00%
The most profitable trade made by Kim Blickenstaff
Kim Blickenstaff's Trading History
Tandem Diabetes Care
May 24, 2024
Director
Uninformative Buy
229.37K
$6.72M
Nuvation Bio
Jun 13, 2024
Director
Informative Buy
499.35K
$444.25K
Medivation
Sep 30, 2016
―
Uninformative Sell
―
$596.78K
Dexcom
―
Director
―
$308.78K
List of latest transactions for each holding click on a transaction to see Kim Blickenstaff's performance on stock
You May Also Like
Kim Blickenstaff insider profile FAQ
What is the percentage of profitable transactions made by Kim Blickenstaff?
The percentage of profitable transactions made by Kim Blickenstaff is 39%.
What is the average return per transaction made by Kim Blickenstaff?
The average return per transaction made by Kim Blickenstaff is 62.90%.
What stocks does Kim Blickenstaff hold?
Kim Blickenstaff holds: TNDM, NUVB, MDVN, DXCM stocks.
What was Kim Blickenstaff’s latest transaction?
Kim Blickenstaff latest transaction was an Informative Buy of $499.35K.
What was Kim Blickenstaff's most profitable transaction?
Kim Blickenstaff’s most profitable transaction was an Informative Buy of TNDM stock on October 17, 2017. The return on the trade was 800.00%.
What is Kim Blickenstaff's role in Tandem Diabetes Care?
Kim Blickenstaff's role in Tandem Diabetes Care is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.